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RAG2-/- gamma(c)-/- mice transplanted with CD34+ cells from
human cord blood show low levels of intestinal engraftment and
are resistant to rectal transmission of human immunodeficiency
virus
Abstract
Rectal transmission is one of the main routes of infection by human immunodeficiency virus type 1
(HIV-1). To efficiently study transmission mechanisms and prevention strategies, a small animal model
permissive for rectal transmission of HIV is mandatory. We tested the susceptibility of
RAG2(-/-)gamma(c)(-/-) mice transplanted with human cord blood hematopoietic stem cells to rectal
infection with HIV. We rectally exposed these humanized mice to cell-free and cell-associated HIV. All
mice remained HIV negative as assessed by plasma viral load. The same mice infected intraperitoneally
showed high levels of HIV replication. In the gut-associated lymphatic tissue, we found
disproportionately smaller numbers of human cells than in other lymphoid organs. This finding may
explain the observed resistance to rectal transmission of HIV. To increase the numbers of local HIV
target cells and the likelihood of HIV transmission, we treated mice with different proinflammatory
stimuli: local application of interleukin-1beta, addition of seminal plasma to the inoculum, or induction
of colitis with dextran sodium sulfate. These procedures attracted some human leukocytes, but the
transmission rate was still very low. The humanized mice showed low levels of human engraftment in
the intestinal tract and seem to be resistant to rectal transmission of HIV, and thus they are an unsuitable
model for this application.
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Rectal transmission is one of the main routes of infection by human immunodeficiency virus type 1 (HIV-1).
To efficiently study transmission mechanisms and prevention strategies, a small animal model permissive for
rectal transmission of HIV is mandatory. We tested the susceptibility of RAG2/c
/mice transplanted with
human cord blood hematopoietic stem cells to rectal infection with HIV. We rectally exposed these humanized
mice to cell-free and cell-associated HIV. All mice remained HIV negative as assessed by plasma viral load. The
same mice infected intraperitoneally showed high levels of HIV replication. In the gut-associated lymphatic
tissue, we found disproportionately smaller numbers of human cells than in other lymphoid organs. This
finding may explain the observed resistance to rectal transmission of HIV. To increase the numbers of local
HIV target cells and the likelihood of HIV transmission, we treated mice with different proinflammatory
stimuli: local application of interleukin-1, addition of seminal plasma to the inoculum, or induction of colitis
with dextran sodium sulfate. These procedures attracted some human leukocytes, but the transmission rate
was still very low. The humanized mice showed low levels of human engraftment in the intestinal tract and seem
to be resistant to rectal transmission of HIV, and thus they are an unsuitable model for this application.
Millions of people worldwide are infected with human im-
munodeficiency virus (HIV). Despite improved treatment
strategies and efforts at prevention, no end of the pandemic is
in view. HIV transmission occurs mostly by sexual intercourse
via mucosal routes (11); rectal intercourse carries an especially
high risk (32) and thus is considered one of the major risk
factors for both homosexual and heterosexual HIV transmis-
sion (7). For the rational design of prevention methods such as
microbicides, we need detailed knowledge of HIV transmission
and in particular the early steps of HIV infection.
HIV research has long been hampered by the lack of a small
animal model that recapitulates HIV infection in humans and
permits the study of vaginal or rectal transmission. Studies with
larger animals can provide important clues to understand
transmission and improve the design of trials in humans. Non-
human primates and, less frequently, cats have been used (1,
8), but these models have significant problems, such as low
availability, high costs, and species differences. HIV is a hu-
man-specific virus, and nonhuman primates and felines are
resistant to HIV. Thus, either simian, simian-human chimeric,
or feline immunodeficiency viruses have to be used as an ap-
proximation for HIV.
Immunodeficient mice transplanted with human cells as an
animal model for HIV disease have numerous advantages and
some shortfalls. Cohort size can be increased significantly, pro-
viding more robust statistical validity to experiments. Mice are
less costly and labor intensive than larger animals, and, nota-
bly, they are susceptible to HIV. Severe combined immuno-
deficient (SCID) mice transplanted with either human fetal
thymus/liver (Thy/Li) or human peripheral blood leukocytes
(PBL) (25) are well-established models. The rate of mucosal
transmission of HIV in hu-PBL-SCID mice is low and variable
(12) and renders this mouse model unsuitable for preclinical
studies of microbicides. Significantly, the SCID-hu Thy/Li
mouse has never been evaluated for mucosal transmission
since human cells are mostly found in the transplanted organ
and peripheral engraftment is low (35).
Recently, we and others reported humanized mice as a
promising new model for HIV research (2, 3, 5, 15, 37, 42, 44).
In these models, transplantation of human hematopoietic
CD34 cells into immunodeficient mice leads to the develop-
ment of all human lymphoid lineages and the repopulation of
lymphoid organs with human cells. These models differ accord-
ing to the mouse strains used (i.e., NOD/SCID, NOG/SCID, or
RAG2/c
/ mice) and the origins of the human hemato-
poietic cells transplanted (i.e., CD34 cells from fetal liver or
cord blood). Previously, we showed sustained and dissemi-
nated HIV replication in RAG2/c
/ mice transplanted
with cord blood CD34 cells after intraperitoneal (i.p.) injec-
tion of HIV (3). So far, only two studies investigating HIV
infection in humanized mice have shown successful HIV infec-
tion by the rectal route (4, 37). In these studies, human trans-
* Corresponding author. Mailing address for Roberto F. Speck and
Ursula Hofer: Division of Infectious Diseases and Hospital Epidemi-
ology, University Hospital of Zurich, Raemistrasse 100, CH-8091
Zurich, Switzerland. Phone for R. F. Speck: 41-44-2553775. Fax:
41-44-2553291. E-mail: roberto.speck@usz.ch. Phone for U. Hofer:
41-44-2559345. Fax: 41-44-2553291. E-mail: ursula.hofer@usz.ch.
 Published ahead of print on 8 October 2008.
12145
 at UNIVERSITATSSPITAL on January 8, 2009 
jvi.asm.org
D
ow
nloaded from
 
plants were obtained from fetal tissue. Aside from any ethical
considerations, fetal tissue is not as easily and widely available
as cord blood. Furthermore, one study used bone marrow/
liver/thymus (BLT) mice, which receive a thymic organ trans-
plant before irradiation and reconstitution with fetal liver-
derived hematopoietic stem cells.
In the present study, we examined mucosal transmission of
HIV in RAG2/c
/ mice transplanted with cord blood-
derived CD34 cells. We characterized the engraftment of
human cells into the gastrointestinal tract of these humanized
mice and determined their susceptibility to rectal transmission
of HIV. We challenged mice with cell-free and cell-associated
HIV since their relative contributions are not known. Overall,
rectal transmission rates were low in all groups of humanized
mice, independently of preinfection treatment and inoculation
protocols.
(This work was presented in part as a poster at the HIV
Pathogenesis Keystone Symposia, Banff, Alberta, Canada, 27
March to 1 April 2008.)
MATERIALS AND METHODS
Generation of humanized mice. Mice were reconstituted as described previ-
ously (3, 39). Briefly, newborn RAG2/c/ mice were irradiated with 2  2
Gy. CD34 cells were isolated from cord blood with immunomagnetic beads
(Milteny Biotec), and 150,000 to 400,000 cells (246,000  60,000) were trans-
planted into each mouse. Fetal liver-derived CD34 cells were a kind gift from
R. Akkina (Colorado State University). Eight to 12 weeks after transplantation,
the levels of blood engraftment were determined by flow cytometry of peripheral
blood mononuclear cells (PBMCs) stained for the human panleukocyte marker
CD45 in all mice (mean human cells/live cells, 11.56%  10.9%). Liver, bone
marrow, and spleen engraftment levels were also analyzed in 14 mice. All ex-
periments were approved and conducted according to local guidelines and laws.
Tissue characterization. Formalin-fixed tissue sections from liver and large
intestines were stained with hematoxylin and eosin (H&E) or for markers for
human CD45 (clones PD7/26 and 2B11 [Dako]), CD4 (clone 1F6 [Novacostra]),
and CD68 (clone GG-M1 [Dako]). To control for nonspecific staining, tissue
from untransplanted mice was stained as well. Human CD45 cells were counted
at a magnification of 200 at 10 randomly chosen locations per organ and
mouse. In interleukin-1 (IL-1)-treated mice, cell numbers were evaluated
separately for the 1.5 cm most proximal to the anus.
Lymphocytes from the small and large intestines (SI and LI, respectively) were
isolated (gut-associated lymphatic tissue [GALT]) (26) sequentially from the
intraepithelial and lamina propria compartments of three mice with a mean
blood engraftment of 13.7%. Briefly, intestines were opened longitudinally, cut
into pieces, and washed five times with cold phosphate-buffered saline (PBS)–2%
fetal calf serum (FCS). Then the epithelial layer was dissociated by stirring tissue
pieces for 30 min in PBS–2% FCS, 2 mM EDTA, and 2 mM dithiothreitol at
37°C. Supernatants were collected and filtered through 70- and 40-m cell
strainers. Cells were washed twice and kept on ice until analysis by flow cytom-
etry. The remaining tissue was incubated for 15 min in cold RPMI–10% FCS and
then stirred at 37°C in RPMI–5% FCS, 100 U/ml collagenase IV, and 10 U/ml
DNase I (both from Sigma) to extract lamina propria cells. After 30 and 60 min
of digestion, supernatants were collected and fresh digestion medium was added
to the tissue pieces after the first collection step. Supernatants were treated as
mentioned above.
Proinflammatory treatment with IL-1. Mice were anesthetized with Keta-
mine and Rompun (50 and 8 mg/kg of body weight, respectively), and 250 U of
recombinant human interleukin IL-1 (Invitrogen) in 25 l of PBS was applied
intrarectally with a pipette 24 h before infection. The mice were suspended head
down for 1 min.
Colitis induction. Colitis was induced by cyclic treatment with 1% (wt/vol)
dextran sodium sulfate (DSS) (molecular weight, 40,000 [MP Biomedicals])
added to the drinking water for 4 days, followed by 7 days of normal drinking
water (21, 43). At the end of the third cycle, colitis was verified in formalin-fixed
tissue sections, or the mice were used for HIV challenges. H&E sections of
DSS-treated and untreated mice were scored for epithelial changes and inflam-
matory infiltration as described previously (36).
HIV infections. For cell-associated HIV infections, the CCR5-tropic HIV
strain YU-2 was used. For cell-free HIV infections, either YU-2, JR-CSF
(CCR5-tropic), NL4-3 (CXCR-4 tropic), or 89.6 (dually tropic) (all prepared
according to reference 3) was used. Cell-associated HIV was prepared by infect-
ing CD8 T-cell-depleted PBMCs pooled from three donors. PBMCs first were
stimulated with 2 g/ml phytohemagglutinin (PHA) for 3 days and then spin-
oculated with YU-2 at a multiplicity of infection of 0.1 for 2 h at 1,200  g and
25°C. After the washing, the cells were returned to culture without further
addition of PHA. Four days after spinoculation, infection rates were measured
by intracellular p24 staining (6.5 to 12.5% positive) and viability was controlled
by Trypan blue staining (90%). Cells were washed twice and suspended in
either PBS or seminal plasma. Cell-free virus stock was used undiluted or mixed
1:1 with seminal plasma. Mice received rectally cell-free stock virus at a dose of
2 105 (YU-2), 5 103 (JR-CSF), 1 104 (89.6), or 2 105 (NL4-3) 50% tissue
culture infective doses (TCID50) or 2  106 infected PBMCs. Anesthesia and
inoculation were performed as described above. Twenty microliters of the re-
spective inoculum was applied per mouse, except for mixtures of cell-free HIV
and seminal plasma, which were given in volumes of 40 l. Mice infected i.p.
received 200 l of cell-free virus, corresponding to 2  106 TCID50. Plasma viral
loads were measured by reverse transcription-PCR (Amplicor; Roche) at 4 to 6
weeks and again at 8 to 12 weeks postinfection. The detection limit was 800
copies/ml.
Tracking of rectally instilled labeled cells. PBMCs were stimulated with PHA,
mock spinoculated, and cultured as described above. Cells were labeled with
carboxyfluorescein succinimidyl ester (CFSE), washed and mixed in 20 l of
either PBS or seminal plasma, and applied rectally at 2  106 cells per mouse.
After 2, 4, and 6 h, the mice were euthanized. Intestinal tissue was removed and
snap-frozen. Cryosections were ethanol fixed and counterstained with DAPI
(4	,6-diamidino-2-phenylindole).
Statistical analysis. GraphPad Prism 5.01 was used for statistical analysis.
Data were analyzed by two-tailed t tests—all unpaired, except for naive mice, in
which cell numbers from liver and rectum from the same mouse were paired.
RESULTS
Low engraftment efficiency of human cells in the intestinal
tract of humanized mice. GALT contributes substantially to
the lymphoid system overall, and thus, its detailed character-
ization is mandatory for estimating its contribution in immu-
nological questions. In humans, GALT contains abundant
numbers of CD4 T cells, the main target cells of HIV. How-
ever, little is known about GALT in humanized mice.
We examined the engraftment of human cells into the gut of
RAG2/c
/ mice transplanted with CD34 cells from hu-
man cord blood. Tissue sections of the rectum and the liver of
14 humanized mice were fixed with formalin and stained for
the human panleukocyte marker CD45. Isolated cells from the
liver, bone marrow, blood and spleen were analyzed for
CD45 cells by flow cytometry. From three additional mice, we
isolated GALT cells: intraepithelial lymphocytes (IEL) and
lamina propria lymphocytes (LPL) from the SI and LI. We
included three wild-type mice as positive controls for the iso-
lation procedure of the GALT.
Human cell numbers in tissue sections of rectum were sig-
nificantly lower than in those from liver (Fig. 1A and B). The
same pattern was seen in flow cytometric analysis: engraftment
levels in the intestines ranged between 0.001 and 0.1%,
whereas in other organs examined, they were up to 800 times
higher (Fig. 1D). The cellular compositions and the protocols
to isolate cells differ substantially, according to tissue. Thus,
comparisons between relative cell numbers in organs are dif-
ficult to interpret. However, GALT lymphocytes from wild-
type mice exhibit large numbers of CD4 cells in the LI LPL
cell fractions (Fig. 1C). Isolation of CD4 cells from wild-type
mice shows that the lack of human cells in the GALT from
humanized mice is not due to technical problems.
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Naive humanized mice are resistant to rectal transmission
of HIV. In body fluids, HIV occurs as free virions (cell free) or is
found inside of infected cells (cell-associated virus). The extent of
cell-free or cell-associated HIV in rectal transmission is unknown.
Infected cells could act as “Trojan horses” to release large num-
bers of virions upon invasion of mucosal tissue.
We exposed five naive (untreated) humanized mice to cell-
free HIV YU-2 at a dose of 2  105 TCID50 per mouse and
FIG. 1. Engraftment levels were disproportionately lower in the gut of humanized mice than in other tissues. Mice were analyzed for
engraftment with human leukocytes by measuring cells positive for the human panleukocyte marker CD45. Tissue sections of rectum and liver of
14 mice were stained for CD45 (A [arrowheads indicate positive cells]), and cells were counted per square centimeter (B [mean and standard
deviation; P 
 0.0094). From three mice, lymphocytes from the intraepithelial space (IEL) and the lamina propria (LPL) from the LI and SI were
isolated. Cells from the liver, spleen, bone marrow, and blood were isolated from 14 mice and analyzed by flow cytometry for proportions of human
CD45 cells. Despite high levels of engraftment in the blood, almost no human cells were detectable in the lamina propria of the LI, where the
majority of CD4 cells were found in wild-type (WT) mice (C). Overall, the level of intestinal engraftment was low, whereas in other organs,
percentages of human cells were high (D). Bars represent 200 m.
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nine mice to cell-associated HIV YU-2 (i.e., 2  106 HIV-
infected PBMCs [range of HIV-positive PBMCs as verified by
intracellular p24 staining, 6.5 to 12.5%]) per mouse. After 4
weeks, all mice were negative for plasma viral load by PCR.
We then injected four of the same mice with cell-free HIV
YU-2 i.p. These four mice then showed high viral loads, while
the remaining rectally exposed mice were still negative 8 weeks
after inoculation (Fig. 2B). We included three mice with no
detectable human engraftment in the blood to verify whether
repopulation with rectally instilled HIV-infected cells would
result in HIV infection. These also tested negative for HIV.
It is possible that the origin of the human stem cells used to
generate humanized mice could influence intestinal engraft-
ment efficiency and subsequently rectal HIV infection rates.
Therefore, we reconstituted nine newborn mice of the same
litter with either cord blood-derived or fetal liver-derived
CD34 cells and 12 weeks later exposed them rectally to cell-
free HIV YU-2 as described above. One of the five mice which
received cord blood cells and none of the four mice reconsti-
tuted with liver derived cells tested HIV positive 1 month after
challenge (Fig. 2B).
The efficiency of rectal transmission varies between different
HIV strains. To exclude that the low rectal transmission rates
we observed were a specific feature of YU-2, we tested three
other viral strains: JR-CSF, 89.6, and NL4-3. Three groups of
six mice received cell-free HIV rectally at a dose of 5  103
(JR-CSF), 1  104 (89.6), or 2  105 (NL4-3) TCID50 per
mouse. Of the 18 mice challenged, none showed a detectable
plasma viral load 4 and 8 weeks after challenge.
We also prepared PBMCs for mock infections. These cells
were labeled with CFSE before rectal instillation to track their
location subsequent to rectal instillation (Fig. 2A). Only a few
single cells had invaded the mucosa after 6 h; most of the
inoculum probably was excreted (Fig. 2C).
While infection rates after i.p. injection of HIV were high,
we rarely detected HIV transmission after rectal exposure,
FIG. 2. Rectal transmission of HIV in naive mice was rare. Naive (untreated) humanized mice were exposed rectally to cell-free (cf) or
cell-associated (ca) HIV, and plasma viral load was measured 4 to 8 weeks later (Amplicor; Roche). Cell-associated HIV was prepared following
a three-step protocol. CD8-depleted PBMCs from three donors were pooled and PHA stimulated and then spinoculated and cultured for 4 more
days (A). Nine mice were inoculated rectally with infected PBMCs; five mice were inoculated with cell-free HIV. Plasma viral load was negative
in all mice. Four of the same mice were then inoculated by i.p. injection, and all became HIV positive (B [squares]). Additional mice were
reconstituted in parallel either with fetal liver-derived (B [triangles; n 
 4]) or with cord blood-derived (B [circles; n 
 5]) CD34 cells and
challenged rectally with cell-free HIV. One of the mice receiving cord blood cells tested HIV positive. A cell migration assay was performed with
mock-spinoculated cells. CFSE-labeled cells were applied rectally to three mice. In cryosections, a few single invading leukocytes (arrowheads)
were detected (C).
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either to cell-free or cell-associated HIV. Our finding that
instilled cells rarely cross the rectal mucosa can explain the
resistance of humanized mice to cell-associated HIV.
Rectal application of IL-1 leads to low levels of infiltration
with human cells. IL-1 is a potent proinflammatory cytokine
and mediates leukocyte chemotaxis. We speculated that local
pretreatment with IL-1 would attract human lymphoid cells
to the rectal mucosa and increase HIV transmission. In some
experiments, we added human seminal plasma to the inocu-
lum. Seminal plasma may have chemotactic potential (6) and
may enhance attachment of HIV to target cells (27). However,
semen has many pro- and antiviral factors (10), and its exact
role in HIV transmission is still unknown.
We treated three humanized mice rectally with 250 U of
IL-1. After 24 h, we detected inflammatory changes, such as
vessel dilatation and cell infiltration, at the site of application
(Fig. 3A). Most of the infiltrating cells were murine, but sig-
nificantly more human cells were found than in untreated mice
(Fig. 3A and B). We detected both human CD4- and CD68-
positive cells in the rectal mucosa at the site of IL-1 applica-
tion (data not shown). This observation confirms that IL-1
attracted some human CD4 cells and macrophages, potential
HIV targets, to the rectal mucosa of humanized mice.
We also pretreated mice with IL-1 and challenged them
24 h later with cell-associated HIV or cell-free HIV, with or
without seminal plasma, at the same doses as the naive mice.
Transmission rates were still low (Fig. 3C). Of 12 mice inocu-
lated with cell-free or cell-associated HIV mixed with seminal
plasma, none developed viremia, while 1 of 5 mice inoculated
with cell-free virus developed viremia.
Additionally, we tracked CFSE-labeled cells after rectal ap-
plication with the IL-1 pretreatment scheme and addition of
seminal plasma to the inoculum. The results were similar to
those described for naive mice: only a few single cells crossed
FIG. 3. Rectal transmission of HIV in mice treated with local proinflammatory stimuli. We treated three humanized mice rectally with 250 IU
IL-1 and checked for inflammation and infiltration with human CD45 cells 24 h later (A [arrowheads indicate positive cells]). Rectal mucosa
proximal to the application site showed an increase in human cells, whereas cell numbers distal to the application site were as low as those in
untreated mice (B [mean and standard deviation, P 
 0.0033]). Mice treated the same way were then exposed to cell-associated (ca) or cell-free
(cf) HIV. In some experiments, seminal plasma (SP) was added to the inoculum. Plasma viral load was measured. One mouse showed viral
replication 4 weeks after HIV challenge (C), and the same results were seen 8 weeks postinfection (not shown). Bars represent 200 m.
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the rectal epithelial layer and penetrated into the mucosa (data
not shown).
Humanized mice are highly susceptible to DSS-induced co-
litis. Concomitant sexually transmitted diseases are important
risk factors for HIV transmission. In particular, mucosal inflam-
mation increases susceptibility to infection by disrupting the epi-
thelial lining and changing the numbers and phenotypes of local
target cells (14). We tried to reproduce this situation in our
humanized mice by inducing a chronic colitis with DSS (43).
So far, DSS colitis has not been studied in humanized mice.
Prior studies established that Rag2/ mice are susceptible to
acute (31) and chronic (17) colitis in the DSS model. In a first
experiment, humanized mice treated with 3% DSS in normal
drinking water for 4 days lost 20% of starting weight and
showed severe clinical symptoms. Therefore, we treated the hu-
manized mice with three cycles of 1% DSS interrupted by 7 days
of normal drinking water and then monitored their weight and
state of health daily (Fig. 4A). Mice tolerated this reduced dose
well and suffered only from minimal weight loss. One week after
the last DSS administration, we analyzed the large intestines of
three mice histologically: tissue sections showed inflammatory
changes with alteration of the epithelial layer and infiltration of
leukocytes, partly of human origin (Fig. 4B to D). Notably, human
cell numbers in the mucosa seen by staining for human CD45
were significantly higher in DSS-treated animals than in animals
that received normal drinking water.
To assess the impact of rectal inflammation on HIV transmis-
sion rate, we challenged mice with cell-associated HIV 7 days
after the last DSS administration. Unexpectedly, 24 h after inoc-
ulation, all mice were severely affected, and some did not recover.
Mortality was 50% in the first week after infection. The remaining
animals recovered completely, and HIV RNA levels were mea-
sured 4 and 8 weeks after HIV inoculation. No infection was
detectable in all three mice that completed the trial. We conclude
that, despite mucosal inflammation, transmission of cell-associ-
ated HIV is improbable in humanized mice.
DISCUSSION
Humanized mice are a promising model for large-scale stud-
ies of HIV transmission, and their characterization is critical to
future studies. Our study describes human engraftment in
FIG. 4. DSS induces colitis in humanized mice. Twelve humanized mice received three cycles of 1% DSS in normal drinking water. This
treatment induced moderate weight changes (A) due to colitis induction. Colitis was confirmed by histological scoring of tissue sections of three
mice (B [P 
 0.0008]). DSS treatment induced cellular infiltration consisting mostly of murine cells since only a fraction of cells were positive for
human CD45 (C [positive cells indicated by black arrowheads]). However, in comparison to untreated mice, human cell numbers were increased
after DSS treatment (D [P 
 0.0005]). DSS-treated mice were then inoculated with HIV (red arrow in panel A). Bars represent 200 m.
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GALT of RAG2/c
/ mice into which have been trans-
planted cord blood-derived CD34 cells. We show that, in this
particular model, human cell numbers in the GALT are lower
than in other lymphatic organs and increase only moderately
after proinflammatory treatment. Furthermore, we examined
the susceptibility of these humanized mice to rectal transmis-
sion of HIV and found a very small rate of rectal transmission
of HIV. Only 2 of 56 challenged mice became HIV positive.
Thus, this model may have limited value for the study of rectal
transmission of HIV.
Two other studies showed successful rectal infections of
humanized mice (4, 37), with transmission rates of 6/7 and
11/14, respectively. Sun et al. (37) used NOD/SCID mice trans-
planted with fetal liver and thymus and later reconstituted with
liver-derived CD34 cells (BLT mice). Berges et al. (4) trans-
planted RAG2/c
/ mice with CD34 cells from fetal
liver. Thus, a major difference is that we used cord blood-
derived cells. So far, it is not clear which source of hematopoi-
etic stem cells is optimal for the generation of humanized mice.
In vitro, the colony-forming efficiency of CD34 cells derived
from fetal liver is higher than that of cord blood CD34 cells
(19). However, in vivo cord blood-derived hematopoietic stem
cells produced four times more mature human leukocytes than
liver-derived cells, when the same number of stem cells was
transplanted into adult NOD/SCID mice (18). When telomere
length is used as a measure of replicative capacity of hemato-
poietic stem cells from fetal liver and cord blood, the differ-
ences are minimal (40), indicating that both are suitable for
generating humanized mice. However, it is not known to what
extent the origin of lymphoid cells may be critical for repopu-
lation of the intestines with human cells. Different expression
of cell adhesion molecules (30) could influence homing behav-
ior and subsequent repopulation of lymphoid organs. That, in
turn, may explain the lower infection rates we observed in our
model using cord blood-derived cells for transplantation. But
when we reconstituted mice in parallel either with cord blood-
derived or with fetal liver-derived cells, rectal transmission of
HIV was not more efficient in the mice which had received
liver-derived cells.
Apart from the different origins of CD34 cells, Berges et al.
and we used similar models based on mice with the same
genetic background. However, Berges et al. reported higher
engraftment levels than the ones we detected. They found
blood engraftment levels of almost 90%, whereas the mice
used in our study had a mean engraftment of about 11%. But
these values cannot be directly compared. Berges et al. mea-
sured the percentage of human cells in blood lymphocytes; we
measured the percentage of human cells in all blood leuko-
cytes, which include murine cells as well. Since RAG2/c
/
mice have no B, T, and NK cells of their own, obviously all
lymphocytes detected in humanized mice should be of human
origin. In our cohort of mice transplanted with liver-derived
cells, we saw no differences in engraftment levels compared to
engraftment levels in littermates transplanted with cord blood-
derived cells. This indicates that the origin of the stem cells
probably has no major impact, at least in our hands, and that
other factors are influencing HIV transmission rates in human-
ized mice.
The intestinal microflora plays important roles in GALT
development: intestinal bacteria influence the migration pat-
tern of lymphocytes into mucosal sites; in germ-free animals,
intestinal lymphocyte numbers are drastically decreased (38).
Certainly, the microflora in the gut of mice from different
genetic backgrounds and from different animal facilities varies
and could influence human engraftment in GALT and subse-
quently HIV transmission susceptibility. Besides potential dif-
ferences in gut microflora, especially in BLT mice, gastroin-
testinal engraftment appears to be significantly better than the
GALT engraftment we obtained in RAG2/c
/ mice. BLT
mice have the advantage of a human thymic tissue transplant,
which could facilitate T-cell development.
In our humanized mouse model, T-lymphocyte development
occurs in the anlage of the murine thymus, which is almost
completely repopulated with human cells. Nonetheless, the
stroma of this thymus is of murine origin and may have un-
known disadvantageous effects on overall lymphoid develop-
ment. Furthermore, to generate BLT mice, the NOD/SCID
mouse strain was used. In contrast to RAG2/c
/ mice,
NOD/SCID mice do not have mutations or loss of c, the
common gamma chain in receptors of multiple cytokines, in-
cluding IL-7. Signaling through the IL-7 receptor is essential
for formation of the Peyer’s patches’ anlagen (28), and human-
ized mice lacking this important feature may have more diffi-
culties in repopulating the GALT than mice that have Peyer’s
patches’ anlagen.
To enrich for human cells of lymphoid origin in the rectal
mucosa in our humanized mouse model, we induced local
inflammation. Mucosal inflammation as seen in sexually trans-
mitted diseases is a risk factor for HIV acquisition by increas-
ing numbers of HIV target cells and disturbing epithelial in-
tegrity (14). We treated humanized mice with Il-1 rectally
24 h before HIV challenge. In untreated mice, no infections
could be seen; in treated mice, 1/17 showed a detectable
plasma viral load. Immunohistochemical analysis of Il-1-
treated uninfected mice suggests that, despite an inflammatory
response and cell infiltration, human cell numbers were prob-
ably still too low to establish infection. It is believed that HIV
first infects a local founder population in the lamina propria of
the mucosal tissue and amplifies there before systemic seeding
and dissemination of the infection (16). In our model, local
expansion of infection is difficult with only a few human cells
present in the lamina propria. We only observed disseminated
infection when mice were injected i.p. with HIV, and the mu-
cosal amplification step was not needed.
To attract human cells more efficiently to the GALT, we
treated humanized mice with DSS, a compound widely used in
murine models of inflammatory bowel disease. Repeated treat-
ment with DSS leads to a chronic colitis with infiltration of
lymphocytes and macrophages (21). After three cycles of DSS
treatment of humanized mice, we also saw infiltration of hu-
man cells into the rectal mucosa. Moreover, we confirmed
colitis induction by monitoring weight changes and finally by
histological scoring of rectal tissue. Mice tolerated treatment
well up to 1 week after the last DSS administration, when a
rapid decline in health occurred and half of the mice had to be
euthanized. The HIV challenge could be a reason for the
observed health decline. However, all mice were similarly af-
fected, even surviving mice, which remained HIV negative.
Notably, in non-DSS-treated mice, the same HIV challenge
never elicited any symptoms. We therefore conclude that the
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DSS chronic colitis model is not suitable for rendering human-
ized mice permissive to rectal challenges with HIV.
It is still unknown whether cell-free or cell-associated HIV is
preferably transmitted. To develop microbicides or vaccines, it
is essential to know whether protection is needed against free
virions, infected cells, or both. In simian and feline models,
both cell-free and cell-associated virus transmission can be
observed with different efficiencies, depending on the experi-
mental design (9, 20, 33). Results from studies in humans are
conflicting: both free virions and infected cells are detected in
cervicovaginal fluid (34) and semen (41). In cervicovaginal
explants, which frequently are used for preclinical microbicide
testing, cell-free HIV and cell-associated HIV are infectious
(23). Here, we detected only minimal transmigration of rectally
applied mononuclear cells into the mucosa both in untreated
and Il-1-treated humanized mice. Further infection experi-
ments with cell-associated HIV confirmed this observation.
None of the mice exposed to HIV-infected PBMCs showed
systemic viral replication, not even mice that had DSS colitis.
Thus, cell-associated HIV transmission is, at least in our
model, not more efficient than cell-free HIV transmission.
HIV strains with selective coreceptor use or even more sub-
tle viral variants may differ in their abilities to establish infec-
tion by the mucosal route. In humans, CCR5-tropic HIV is
transmitted preferably over CXCR4-tropic HIV (24), and even
in the group of CCR5 viruses, potential for transmission is
diverse. Patients during acute infection show a more homoge-
nous viral population, whereas patients in the chronic phase
harbor many distinct variants (13, 29), indicating that only
some of the viral variants in the transmitter are passed on.
However, the characteristics of HIV variants preferentially
transmitted are unknown so far. The CCR5-tropic HIV variant
YU-2, which we used in our study for rectal challenge, was first
isolated from neural tissue of a child suffering from AIDS (22).
There is some uncertainty whether it is easily transmitted by
the mucosal route or not. In any case, YU-2 replicates well in
humanized mice and establishes disseminated infection after
i.p. injection (3), and the three other HIV strains we tested in
this study were not more efficient in rectal transmission of
HIV. The other two studies (4, 37) demonstrating mucosal
transmission of HIV in humanized mice showed that the mice
were permissive to CXCR4-tropic HIV infection by the rectal
route. However, Sun et al. challenged mice with HIV after
mechanical disruption of the epithelial layer. It remains un-
known whether the CXCR4-tropic viral strain used would have
been transmitted otherwise. So far, we do not know whether
the same bottleneck seen in humans for mucosal transmission
of HIV exists in humanized mice.
In conclusion, our data indicate that GALT reconstitution in
RAG2/c
/ mice transplanted with CD34 cells from cord
blood is low and these mice seem to be quite resistant to rectal
transmission of HIV, even in an inflammatory setting. Their
value to study measures preventing mucosal transmission of
HIV probably is limited. Further efforts are needed to clarify
which mouse strain and transplantation protocol are best
suited to generate the optimal humanized mouse.
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